WEST PACES ADVISORS INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2004720 ATLANTA, GA

Position in REGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$15,588

-$1,536 QoQ

Shares Held

-7.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#338

of 406 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WEST PACES ADVISORS INC. holds $58,541 across 13 Biotechnology names. REGN ranks #1 (26.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	25	$15,588
2	INSM	INSMED Inc	98	$10,448
3	CRSP	CRISPR Therapeutics AG	153	$8,344
4	VRTX	Vertex Pharmaceuticals Inc / Ma	12	$5,960
5	ABVX	Abivax S.A.	41	$5,463
6	PTCT	Ptc Therapeutics, Inc.	50	$4,078
7	BLTE	Belite Bio, Inc	18	$2,771
8	QURE	uniQure N.V.	59	$2,717

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,588	25	-7.4%	Shares	Sole	2026-07-20
2025-03-31	$17,124	27	0.0%	Shares	Sole	2025-04-15
2024-12-31	$19,232	27	0.0%	Shares	Sole	2025-02-14
2024-09-30	$28,383	27	0.0%	Shares	Sole	2024-10-15
2024-06-30	$28,377	27	0.0%	Shares	Sole	2024-07-17
2024-03-31	$25,987	27	+575.0%	Shares	Sole	2024-04-15
2023-12-31	$3,513	4	+100.0%	Shares	Sole	2024-01-30
2023-09-30	$1,645	2	0.0%	Shares	Sole	2023-12-18
2023-06-30	$1,437	2	-33.3%	Shares	Sole	2023-12-18
2023-03-31	$2,465	3	+50.0%	Shares	Sole	2023-12-18
2022-12-31	$1,442	2	0.0%	Shares	Sole	2023-12-18
2022-09-30	$1,377	2	0.0%	Shares	Sole	2023-12-19
2022-03-31	$1,396	2	-95.0%	Shares	Sole	2023-12-19
2021-03-31	$18,925	40	—	Shares	Sole	2023-12-20
No filing history on record for this holder in this stock.